INVO Fertility Inc (IVF) concluded trading on Wednesday at a closing price of $1.02, with 8.52 million shares of worth about $8.69 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -88.82% during that period and on June 25, 2025 the price saw a gain of about 2.00%. Currently the company’s common shares owned by public are about 2.16M shares, out of which, 2.10M shares are available for trading.
Stock saw a price change of -18.40% in past 5 days and over the past one month there was a price change of -39.29%. Year-to-date (YTD), IVF shares are showing a performance of -89.88% which decreased to -89.51% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.97 but also hit the highest price of $17.04 during that period. The average intraday trading volume for INVO Fertility Inc shares is 2.23 million. The stock is currently trading -27.45% below its 20-day simple moving average (SMA20), while that difference is down -41.60% for SMA50 and it goes to -82.76% lower than SMA200.
INVO Fertility Inc (NASDAQ: IVF) currently have 2.16M outstanding shares and institutions hold larger chunk of about 5.28% of that.
The stock has a current market capitalization of $2.20M and its 3Y-monthly beta is at 2.14. It has posted earnings per share of -$35.60 in the same period. It has Quick Ratio of 0.07 while making debt-to-equity ratio of 1.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IVF, volatility over the week remained 6.34% while standing at 4.43% over the month.
Analysts are in expectations that INVO Fertility Inc (IVF) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is -0.98 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 96.32% while it is estimated to increase by 11.71% in next year. EPS is likely to grow at an annualized rate of 60.65% for next 5-years, compared to annual growth of 22.38% made by the stock over the past 5-years.
